Headline: A Game-Changer in Italy‘s Healthcare: New Services Become Free in 2025
Italy’s healthcare landscape is set to transform significantly from December 30, 2024, with a myriad of new services becoming free, courtesy of the Servizio Sanitario Nazionale (SSN). Many of these updates were long overdue, with ambulatory and medical assistance tariffs remaining stagnant since 1996 and 1999, respectively.
The most anticipated changes include:
-
Advances in Radiotherapy and Biologics: Many high-end radiotherapies and biologics, previously requiring hospitalisation, will now be accessible on an ambulatory basis.
-
Cataract Surgery Revisions: Interventions on cataracts have had their pricing updated, making them more affordable for patients.
- Celiac Disease Screening: The SSN will now cover screening for celiac disease, potentially helping more people receive early detection and treatment.
Among the new, completely free services are:
-
Advanced Prosthetics: Updates to prosthetics for upper and lower limbs will be offered for free.
-
Procreative Medicine Assistance (PMA): The cycles for PMA treatments will be fully covered by the SSN, marking a significant step forward in reproductive rights.
- Ingestible Diagnostic Devices: Video capsules, used for diagnosing intestinal issues, will now be available as SSN services.
While these changes are generally welcomed, some areas remain unaddressed, such as:
- Autism Therapies: Despite being previously recognised, Applied Behavior Analysis (ABA) therapies aren’t yet covered by the new plan.
-
Endometriosis and Fibromyalgia Treatments: More coverage is needed for the treatment of these conditions.
Validators like Cittadinanzattiva have emphasised the necessity for periodic updates to the Livelli Essenziali di Assistenza (LEA) and tariffs to keep pace with evolving health needs.
Amidst the positives, the issue of ‘health poverty’ lingers — a rising number of people struggle to afford medications and treatments. In 2024, roughly 463,000 Italians sought pharmaceutical assistance, an 8% increase from the previous year.
The upcoming shifts, while not solving this issue comprehensively, will certainly ease some financial burdens on patients and expand access to essential healthcare services.
